2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$66.46-$0.24 (-0.36%)
Price as of Aug 21, 2026 7:30 PM EDT- $12.9BMarket Cap
- 13.86%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$66.46-$0.24 (-0.36%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $66.70 | ||
Change | -$0.98 (-1.45%) | ||
Open | $67.55 | ||
High | $68.34 | ||
Low | $66.52 | ||
Previous Close | $67.68 | ||
Volume | 1,593,613 | ||
30-Day Average Volume | 2,262,436 | ||
1-Week Change | -0.98% | ||
1-Month Change | 12.65% | ||
1-Year Change | 13.86% | ||
3-Year Change | -25.78% | ||
5-Year Change | -11.23% | ||
Fundamentals | |||
Shares Outstanding | 193.6M | ||
Total Assets | $11.7B | ||
Market Cap | $12.9B | ||
Enterprise Value | $16.2B | ||
Period: QTR TTM FY | |||
Revenue | $984.4M | ||
Net Income | $44.8M | ||
Free Cash Flow | $139.3M | ||
EBIT | $122.1M | ||
EBITDA | $219.8M | ||
Net Working Capital | $2.3B | ||
EPS | $0.23 | ||
Enterprise Value/EBITDA | 74 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 2 | ||
P/E | 290 | ||
PEG | -5 | ||
Price/Free Cash Flow | 93 | ||
Price/Operating Cash Flow | 77 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue